Advertisement

Topics

Atomo Diagnostics and Access Bio Inc. Company Profile

04:52 EST 11th December 2018 | BioPortfolio


News Articles [411 Associated News Articles listed on BioPortfolio]

Mylan partners with Atomo Diagnostics to expand access to HIV self-testing in low and middle-income Countries

The tests will allow individuals to confidently screen themselves in the privacy of their own homes with a device engineered for simplicity and accuracy. The tests are designed The post Mylan partner...

Atomo Diagnostics: Award winning revolutionary technology

Atomo Diagnostics is a medical technology company bringing next generation rapid diagnostic solutions to market and radically changing the way that we diagnose disease. AtomoRapid™ has launched in A...

Mylan gets rights to sell Atomo's HIV self-test in over 100 countries worldwide

Atomo Diagnostics licensed Mylan NV exclusive rights to commercialize rapid self-tests for HIV in over 100 low- and middle-income countries.

Deals this week: Mylan, Daiichi Sankyo, Takeda

Mylan has formed a partnership with Atomo Diagnostics to expand access to HIV self-testing products in developing and under-developed countries....Read More... The post Deals this week: Mylan, Daiichi...

Quest Diagnostics Acquires PhenoPath, Broadening Access to Advanced Diagnostics

SECAUCUS, N.J. and SEATTLE, Sept. 27, 2018 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has a...

Strand Life Sciences to acquire Quest Diagnostics' Indian diagnostics business

Quest Diagnostics, the world's leading provider of diagnostic information services, announced an agreement to sell its India medical diagnostics business to Strand Life Sciences, a Bengaluru─based s...

Emosis, 5─Diagnostics ink exclusive distribution deal for Emo─test, HIT Confirm, in CE Mark─regulated countries

Emosis, a medical device company specialising in cytomolecular diagnostics of hemostasis disorders, and 5─Diagnostics (5─D), a worldwide distributor for haemostasis products and in─vitro diagnos...

2018 Thermo Fisher: Market Shares and Competitive Position by Product and CountryPerformance, Capabilities, Goals and Strategies in the Global Diagnostics Industry [Report Updated: 01011970] Prices from USD $4250

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by pr...

Drugs and Medications [58 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Formucare triple antibiotic [Access Business Group International LLC]

Access Business Group International LLC Triple Antibiotic Drug Facts

Fulton street market athletes foot [Access Business Group LLC]

Access Business Group LLC Athlete's Foot Cream Drug Facts

Formu care calcium antacid [Access Business Group LLC]

Access Business Group LLC Calcium Antacid Tablets Drug Facts

Formucare ranitidine [Access Business Group International LLC]

Access Business Group International LLC Ranitidine 75 Drug Facts

PubMed Articles [904 Associated PubMed Articles listed on BioPortfolio]

Dizziness and vertigo associated with vestibular neuronitis: the approaches to the diagnostics and treatment.

This article is focused on the peculiar features of diagnostics and treatment of dizziness and vertigo in the patients presenting with vestibular neuronitis. The authors present the detailed overview ...

Statistical primer: checking model assumptions with regression diagnostics.

Regression modelling is an important statistical tool frequently utilized by cardiothoracic surgeons. However, these models-including linear, logistic and Cox proportional hazards regression-rely on c...

Planning and evaluation for vascular access in the elderly.

Vascular access is of vital importance for patients requiring dialysis therapies. AV fistulas have been endorsed by many professional societies as the access of choice, however, subsequent creation do...

SwissFEL Aramis beamline photon diagnostics.

The SwissFEL Aramis beamline, covering the photon energies between 1.77 keV and 12.7 keV, features a suite of online photon diagnostics tools to help both users and FEL operators in analysing data...

Access to a scale and self-weighing habits among public housing residents.

Having access to a scale is essential for individuals to engage in self-weighing; however, few studies examine scale access, particularly among low-income individuals. Our objectives were to (i) deter...

Clinical Trials [1773 Associated Clinical Trials listed on BioPortfolio]

Performance and Usability Evaluation of the Atomo HIV Self-Test

The study seeks to enroll 501+ patients to use a HIV self testing device to test for HIV in a blood sample drawn by finger prick. The purpose of the trial is to assess the usability of the...

Innovations in HIV Testing (TI)

The investigators propose to improve HIV prevention and care through expanding HIV testing options to include self-testing for young women, their peers and their sex partners, and by facil...

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Major Research Aim: To study novel molecular diagnostics and the pharmacokinetic variability among a spectrum of TB disease states, including severe forms of TB like disseminated TB, TB me...

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

Companies [1804 Associated Companies listed on BioPortfolio]

Atomo Diagnostics and Access Bio Inc.

JFK Communications, Inc.

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and co...

Gold Standard Diagnostics, Corp.

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, ...

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

Quest Diagnostics Incorporated

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest ac...

More Information about "Atomo Diagnostics and Access Bio Inc." on BioPortfolio

We have published hundreds of Atomo Diagnostics and Access Bio Inc. news stories on BioPortfolio along with dozens of Atomo Diagnostics and Access Bio Inc. Clinical Trials and PubMed Articles about Atomo Diagnostics and Access Bio Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Atomo Diagnostics and Access Bio Inc. Companies in our database. You can also find out about relevant Atomo Diagnostics and Access Bio Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record